Loretta Itri's most recent trade in Whitehawk Therapeutics Inc. was a trade of 76,813 Stock option (right to buy) done . Disclosure was reported to the exchange on March 1, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Whitehawk Therapeutics Inc. | Loretta Itri | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 76,813 | 76,813 | - | - | Stock option (right to buy) | |
Whitehawk Therapeutics Inc. | Loretta Itri | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 60,000 | 60,000 | - | - | Stock option (right to buy) | |
Whitehawk Therapeutics Inc. | Loretta Itri | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 30,000 | 30,000 | - | - | Restricted Stock Units | |
Whitehawk Therapeutics Inc. | Loretta Itri | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 102,350 | 102,350 | - | - | Stock option (right to buy) | |
Whitehawk Therapeutics Inc. | Loretta Itri | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 67,300 | 67,300 | - | - | Stock option (right to buy) |